XML 15 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues:        
Total revenues $ 314,000 $ 392,000 $ 904,000 $ 753,000
Operating expenses:        
Research and development 1,762,000 1,931,000 5,999,000 5,387,000
Selling, general and administrative 4,292,000 4,477,000 11,689,000 10,434,000
Total operating expenses 7,895,000 6,585,000 21,151,000 16,145,000
Loss from operations (7,581,000) (6,193,000) (20,247,000) (15,392,000)
Interest expense (23,000) (3,000) (32,000) (3,000)
Other income, net   119,000 83,000 339,000
Change in fair value of common stock warrant liabilities 1,130,000 (7,777,000) 6,212,000 (6,790,000)
Loss on extinguishment of warrant liability (682,000)   (635,000)  
Offering costs   (336,000)   (702,000)
Net loss before income taxes (7,156,000) (14,190,000) (14,619,000) (22,548,000)
Income tax benefit (provision) (9,000) 3,000 (15,000) (14,000)
Net loss (7,165,000) (14,187,000) (14,634,000) (22,562,000)
Net loss attributable to non-controlling interest (774,000)   (1,081,000)  
Net loss attributable to common stockholders $ (6,391,000) $ (14,187,000) $ (13,553,000) $ (22,562,000)
Net loss per share attributable to common stockholders:        
Basic and diluted $ (0.60) $ (2.04) $ (1.42) $ (4.03)
Weighted-average number of shares used in per share calculations:        
Basic and Diluted 10,719,618 6,942,612 9,570,259 5,596,545
Other comprehensive loss, net of tax        
Unrealized losses on available-for-sale securities   $ (1,000) $ (1,000)  
Other comprehensive loss   (1,000) (1,000)  
Comprehensive loss attributable to common stockholders $ (6,391,000) (14,188,000) (13,554,000) $ (22,562,000)
Product        
Revenues:        
Total revenues 245,000 216,000 630,000 485,000
Operating expenses:        
Cost of product revenues 1,841,000 177,000 3,463,000 324,000
License        
Revenues:        
Total revenues 10,000 17,000 110,000 17,000
Royalty        
Revenues:        
Total revenues 16,000   58,000  
Contract Research And Government Grants        
Revenues:        
Total revenues $ 43,000 $ 159,000 $ 106,000 $ 251,000